CA Patent

CA2927661A1 — Solid forms of ivacaftor and processes for the preparation thereof

Assigned to Apotex Inc · Expires 2015-05-21 · 11y expired

What this patent protects

Provided herein is a polymorphic form of Ivacaftor, namely APO-I, as well as processes for the preparation and pharmaceutical compositions of the same. Also, provided is a new solvate of Ivacaftor, processes for its preparation and use in the preparation of pure Ivacaftor.

USPTO Abstract

Provided herein is a polymorphic form of Ivacaftor, namely APO-I, as well as processes for the preparation and pharmaceutical compositions of the same. Also, provided is a new solvate of Ivacaftor, processes for its preparation and use in the preparation of pure Ivacaftor.

Drugs covered by this patent

Patent Metadata

Patent number
CA2927661A1
Jurisdiction
CA
Classification
—
Expires
2015-05-21
Drug substance claim
No
Drug product claim
No
Assignee
Apotex Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.